Lisa Hines
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 51 | 2023 | 1846 | 3.600 |
Why?
| Genetic Predisposition to Disease | 23 | 2017 | 2090 | 1.210 |
Why?
| Receptors, Estrogen | 11 | 2021 | 371 | 1.050 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 1880 | 0.890 |
Why?
| Case-Control Studies | 35 | 2023 | 3003 | 0.860 |
Why?
| Emigrants and Immigrants | 1 | 2023 | 107 | 0.740 |
Why?
| Alcohol Drinking | 8 | 2017 | 650 | 0.730 |
Why?
| Risk Factors | 38 | 2023 | 8614 | 0.650 |
Why?
| Middle Aged | 53 | 2023 | 26605 | 0.560 |
Why?
| Coronary Disease | 3 | 2005 | 348 | 0.550 |
Why?
| Receptors, Progesterone | 7 | 2021 | 319 | 0.540 |
Why?
| Adenylyl Cyclases | 2 | 2006 | 83 | 0.520 |
Why?
| Adult | 51 | 2023 | 30375 | 0.490 |
Why?
| Substance-Related Disorders | 2 | 2017 | 942 | 0.460 |
Why?
| Suicide, Attempted | 1 | 2017 | 316 | 0.460 |
Why?
| Aged | 42 | 2021 | 18969 | 0.450 |
Why?
| Genetics | 1 | 2014 | 27 | 0.440 |
Why?
| Science | 1 | 2014 | 48 | 0.420 |
Why?
| Female | 62 | 2023 | 59324 | 0.420 |
Why?
| Depressive Disorder, Major | 2 | 2006 | 301 | 0.410 |
Why?
| Menopause | 8 | 2020 | 271 | 0.410 |
Why?
| Suicidal Ideation | 1 | 2017 | 402 | 0.410 |
Why?
| Faculty | 1 | 2014 | 126 | 0.410 |
Why?
| Mental Health | 1 | 2017 | 559 | 0.390 |
Why?
| Energy Metabolism | 4 | 2022 | 727 | 0.380 |
Why?
| Phenotype | 4 | 2011 | 2784 | 0.380 |
Why?
| Postmenopause | 4 | 2014 | 301 | 0.380 |
Why?
| Mammography | 2 | 2009 | 101 | 0.370 |
Why?
| Healthcare Disparities | 9 | 2016 | 479 | 0.360 |
Why?
| Breast Feeding | 3 | 2019 | 366 | 0.350 |
Why?
| Genotype | 13 | 2016 | 1757 | 0.350 |
Why?
| Vocabulary, Controlled | 1 | 2010 | 41 | 0.330 |
Why?
| Alcoholism | 4 | 2017 | 710 | 0.320 |
Why?
| Students | 1 | 2014 | 499 | 0.320 |
Why?
| Sex Characteristics | 4 | 2006 | 636 | 0.320 |
Why?
| Biomarkers, Tumor | 4 | 2022 | 1032 | 0.310 |
Why?
| Humans | 66 | 2023 | 114045 | 0.310 |
Why?
| Alcohol Dehydrogenase | 2 | 2005 | 15 | 0.300 |
Why?
| Diet | 5 | 2015 | 1080 | 0.300 |
Why?
| San Francisco | 4 | 2023 | 54 | 0.300 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2008 | 38 | 0.300 |
Why?
| Polymorphism, Genetic | 3 | 2014 | 610 | 0.290 |
Why?
| Aldehyde Oxidoreductases | 3 | 2004 | 29 | 0.280 |
Why?
| Parity | 4 | 2022 | 97 | 0.280 |
Why?
| Estrogen Replacement Therapy | 1 | 2008 | 116 | 0.280 |
Why?
| Hormones | 2 | 2012 | 132 | 0.260 |
Why?
| United States | 14 | 2023 | 12137 | 0.260 |
Why?
| Mexico | 5 | 2019 | 162 | 0.250 |
Why?
| Odds Ratio | 7 | 2018 | 951 | 0.250 |
Why?
| Mass Screening | 2 | 2009 | 979 | 0.240 |
Why?
| Lipoproteins, HDL | 1 | 2005 | 76 | 0.240 |
Why?
| Indians, North American | 6 | 2015 | 564 | 0.230 |
Why?
| Menstruation | 2 | 2021 | 35 | 0.230 |
Why?
| Life Style | 3 | 2015 | 428 | 0.230 |
Why?
| Transforming Growth Factor beta | 3 | 2013 | 445 | 0.230 |
Why?
| Algorithms | 2 | 2010 | 1469 | 0.210 |
Why?
| Aldehyde Dehydrogenase | 2 | 2017 | 102 | 0.200 |
Why?
| Blood Platelets | 1 | 2005 | 326 | 0.200 |
Why?
| Health Status Disparities | 4 | 2017 | 200 | 0.200 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2022 | 38 | 0.200 |
Why?
| Southwestern United States | 5 | 2015 | 90 | 0.190 |
Why?
| Genetic Association Studies | 4 | 2022 | 339 | 0.180 |
Why?
| Adiposity | 2 | 2016 | 458 | 0.180 |
Why?
| Logistic Models | 7 | 2020 | 1829 | 0.180 |
Why?
| Age Factors | 6 | 2018 | 2885 | 0.170 |
Why?
| Genetic Variation | 3 | 2014 | 868 | 0.170 |
Why?
| Menarche | 1 | 2020 | 49 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 286 | 0.170 |
Why?
| Smoking | 3 | 2015 | 1382 | 0.170 |
Why?
| Young Adult | 10 | 2021 | 10444 | 0.150 |
Why?
| Premenopause | 4 | 2022 | 105 | 0.150 |
Why?
| Reproductive History | 1 | 2018 | 12 | 0.150 |
Why?
| Body Size | 2 | 2015 | 90 | 0.140 |
Why?
| Body Mass Index | 7 | 2015 | 1957 | 0.140 |
Why?
| Incidence | 6 | 2016 | 2314 | 0.140 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2016 | 76 | 0.130 |
Why?
| Triple Negative Breast Neoplasms | 1 | 2018 | 157 | 0.130 |
Why?
| Cigarette Smoking | 1 | 2017 | 74 | 0.130 |
Why?
| Socioeconomic Factors | 2 | 2017 | 1080 | 0.120 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2015 | 269 | 0.120 |
Why?
| Matrix Metalloproteinases | 2 | 2013 | 89 | 0.120 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2014 | 13 | 0.120 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2014 | 58 | 0.120 |
Why?
| Oxidative Stress | 2 | 2013 | 1068 | 0.120 |
Why?
| Aromatase | 1 | 2014 | 30 | 0.120 |
Why?
| Waist Circumference | 1 | 2014 | 122 | 0.110 |
Why?
| Selenoprotein P | 1 | 2013 | 3 | 0.110 |
Why?
| Immunity | 1 | 2014 | 121 | 0.110 |
Why?
| Postpartum Period | 2 | 2022 | 275 | 0.110 |
Why?
| Women's Health | 3 | 2016 | 270 | 0.110 |
Why?
| Aged, 80 and over | 9 | 2016 | 6306 | 0.110 |
Why?
| Schizosaccharomyces | 1 | 2014 | 53 | 0.110 |
Why?
| Models, Educational | 1 | 2014 | 82 | 0.110 |
Why?
| Endonucleases | 1 | 2013 | 30 | 0.110 |
Why?
| Telomere Homeostasis | 1 | 2013 | 24 | 0.110 |
Why?
| Social Justice | 1 | 2013 | 67 | 0.110 |
Why?
| Inflammation | 2 | 2014 | 2464 | 0.110 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 34 | 0.110 |
Why?
| Genetics, Population | 1 | 2014 | 187 | 0.100 |
Why?
| Prognosis | 5 | 2022 | 3315 | 0.100 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2012 | 24 | 0.100 |
Why?
| Tobacco Smoke Pollution | 1 | 2015 | 217 | 0.100 |
Why?
| California | 2 | 2018 | 351 | 0.100 |
Why?
| C-Reactive Protein | 1 | 2014 | 362 | 0.100 |
Why?
| Cross-Sectional Studies | 2 | 2017 | 4402 | 0.100 |
Why?
| Interleukins | 1 | 2014 | 236 | 0.100 |
Why?
| Obesity | 3 | 2016 | 2505 | 0.100 |
Why?
| Bone Morphogenetic Proteins | 1 | 2012 | 132 | 0.100 |
Why?
| Aspirin | 1 | 2014 | 324 | 0.100 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 296 | 0.100 |
Why?
| Neovascularization, Pathologic | 1 | 2013 | 280 | 0.100 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 347 | 0.100 |
Why?
| Genome | 1 | 2014 | 269 | 0.090 |
Why?
| Registries | 3 | 2018 | 1764 | 0.090 |
Why?
| Universities | 1 | 2014 | 338 | 0.090 |
Why?
| Perception | 1 | 2014 | 309 | 0.090 |
Why?
| Telomerase | 1 | 2013 | 204 | 0.090 |
Why?
| Risk | 4 | 2015 | 810 | 0.090 |
Why?
| Telomere | 1 | 2013 | 202 | 0.090 |
Why?
| Dietary Fats | 2 | 2015 | 287 | 0.090 |
Why?
| Anxiety | 1 | 2017 | 843 | 0.090 |
Why?
| Research | 1 | 2014 | 389 | 0.090 |
Why?
| Breast | 3 | 2017 | 138 | 0.090 |
Why?
| Cross Infection | 1 | 2012 | 194 | 0.090 |
Why?
| Risk Assessment | 4 | 2022 | 2958 | 0.090 |
Why?
| RNA | 1 | 2016 | 806 | 0.090 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 192 | 0.090 |
Why?
| Population Surveillance | 3 | 2018 | 385 | 0.080 |
Why?
| Weight Gain | 1 | 2013 | 453 | 0.080 |
Why?
| Mammary Glands, Human | 1 | 2010 | 60 | 0.080 |
Why?
| Male | 9 | 2017 | 55396 | 0.080 |
Why?
| Mammary Glands, Animal | 1 | 2010 | 117 | 0.080 |
Why?
| Depression | 1 | 2017 | 1133 | 0.080 |
Why?
| Gene-Environment Interaction | 3 | 2015 | 182 | 0.080 |
Why?
| Proteomics | 2 | 2006 | 815 | 0.080 |
Why?
| Natural Language Processing | 1 | 2010 | 72 | 0.080 |
Why?
| Macrophage Activation | 1 | 2010 | 163 | 0.080 |
Why?
| Transcription Factors | 2 | 2013 | 1526 | 0.080 |
Why?
| Follow-Up Studies | 4 | 2021 | 4392 | 0.080 |
Why?
| Liver | 1 | 2016 | 1633 | 0.080 |
Why?
| Ovarian Neoplasms | 1 | 2013 | 386 | 0.080 |
Why?
| Staphylococcal Infections | 1 | 2012 | 340 | 0.080 |
Why?
| Research Design | 1 | 2014 | 919 | 0.070 |
Why?
| Colorectal Neoplasms | 2 | 2006 | 592 | 0.070 |
Why?
| Collagen | 1 | 2010 | 414 | 0.070 |
Why?
| Biomarkers | 3 | 2010 | 3397 | 0.070 |
Why?
| Family Health | 1 | 2008 | 193 | 0.070 |
Why?
| Neoplasm Staging | 3 | 2016 | 1162 | 0.070 |
Why?
| Chi-Square Distribution | 1 | 2008 | 492 | 0.070 |
Why?
| Colorado | 2 | 2014 | 4090 | 0.070 |
Why?
| Eye Proteins | 1 | 2007 | 70 | 0.070 |
Why?
| Cornea | 1 | 2007 | 102 | 0.070 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 5 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2008 | 1690 | 0.070 |
Why?
| DNA-Binding Proteins | 1 | 2013 | 1311 | 0.070 |
Why?
| Lens, Crystalline | 1 | 2007 | 90 | 0.060 |
Why?
| Genetic Linkage | 1 | 2006 | 294 | 0.060 |
Why?
| Patient Compliance | 1 | 2009 | 524 | 0.060 |
Why?
| DNA, Complementary | 1 | 2006 | 255 | 0.060 |
Why?
| International Agencies | 1 | 2005 | 29 | 0.060 |
Why?
| World Health Organization | 1 | 2005 | 101 | 0.060 |
Why?
| Antioxidants | 1 | 2008 | 529 | 0.060 |
Why?
| Cataract | 1 | 2007 | 184 | 0.060 |
Why?
| Prevalence | 1 | 2010 | 2247 | 0.060 |
Why?
| Cause of Death | 2 | 2016 | 362 | 0.060 |
Why?
| Sex Distribution | 1 | 2005 | 336 | 0.060 |
Why?
| Antidepressive Agents | 1 | 2005 | 195 | 0.060 |
Why?
| Gene Frequency | 1 | 2005 | 476 | 0.060 |
Why?
| Genome-Wide Association Study | 3 | 2015 | 1176 | 0.050 |
Why?
| Retinal Dehydrogenase | 2 | 2017 | 33 | 0.050 |
Why?
| Signal Transduction | 5 | 2016 | 4501 | 0.050 |
Why?
| Databases, Bibliographic | 1 | 2003 | 29 | 0.050 |
Why?
| Macrophages | 1 | 2010 | 1259 | 0.050 |
Why?
| Linear Models | 1 | 2005 | 768 | 0.050 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2016 | 2087 | 0.050 |
Why?
| Amino Acid Sequence | 1 | 2006 | 1981 | 0.050 |
Why?
| Survival Analysis | 2 | 2017 | 1206 | 0.050 |
Why?
| Pregnancy | 3 | 2022 | 5499 | 0.050 |
Why?
| Homeostasis | 2 | 2016 | 570 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2006 | 2783 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2004 | 300 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2006 | 1947 | 0.050 |
Why?
| Societies, Medical | 1 | 2005 | 655 | 0.050 |
Why?
| Hemostasis | 1 | 2001 | 64 | 0.050 |
Why?
| Survivors | 2 | 2016 | 412 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 4680 | 0.050 |
Why?
| Age of Onset | 2 | 2016 | 444 | 0.050 |
Why?
| Adolescent | 4 | 2021 | 17800 | 0.050 |
Why?
| Neoplasm Invasiveness | 2 | 2016 | 438 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2022 | 1791 | 0.040 |
Why?
| Survival Rate | 2 | 2014 | 1638 | 0.040 |
Why?
| Ethanol | 1 | 2004 | 534 | 0.040 |
Why?
| Biomedical Research | 1 | 2005 | 582 | 0.040 |
Why?
| Computational Biology | 1 | 2003 | 528 | 0.040 |
Why?
| Proportional Hazards Models | 1 | 2022 | 1078 | 0.040 |
Why?
| Animals | 5 | 2016 | 31565 | 0.040 |
Why?
| Genomics | 1 | 2003 | 631 | 0.040 |
Why?
| Cohort Studies | 2 | 2022 | 4883 | 0.040 |
Why?
| Lipids | 1 | 2001 | 564 | 0.040 |
Why?
| Mice | 3 | 2010 | 14843 | 0.040 |
Why?
| Myocardial Infarction | 1 | 2004 | 932 | 0.030 |
Why?
| Rats, Inbred SHR | 1 | 2016 | 41 | 0.030 |
Why?
| Lod Score | 1 | 2016 | 65 | 0.030 |
Why?
| Gene Ontology | 1 | 2016 | 46 | 0.030 |
Why?
| Poultry | 1 | 2016 | 9 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 273 | 0.030 |
Why?
| Red Meat | 1 | 2016 | 13 | 0.030 |
Why?
| Neuropeptide Y | 1 | 2016 | 13 | 0.030 |
Why?
| Cholecystokinin | 1 | 2016 | 15 | 0.030 |
Why?
| Receptors, Ghrelin | 1 | 2016 | 7 | 0.030 |
Why?
| Prospective Studies | 2 | 2013 | 6195 | 0.030 |
Why?
| Receptors, Leptin | 1 | 2016 | 24 | 0.030 |
Why?
| Interviews as Topic | 2 | 2008 | 575 | 0.030 |
Why?
| SEER Program | 1 | 2016 | 195 | 0.030 |
Why?
| Linkage Disequilibrium | 1 | 2016 | 245 | 0.030 |
Why?
| Fishes | 1 | 2016 | 80 | 0.030 |
Why?
| Survival | 1 | 2015 | 37 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 441 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2015 | 1 | 0.030 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 2015 | 12 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 14 | 1 | 2015 | 6 | 0.030 |
Why?
| Meat | 1 | 2016 | 87 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2015 | 15 | 0.030 |
Why?
| Dual-Specificity Phosphatases | 1 | 2015 | 10 | 0.030 |
Why?
| Immune System | 1 | 2016 | 171 | 0.030 |
Why?
| Dietary Fiber | 1 | 2015 | 40 | 0.030 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2014 | 11 | 0.030 |
Why?
| Population Groups | 1 | 2015 | 55 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 17 | 0.030 |
Why?
| Janus Kinase 1 | 1 | 2014 | 23 | 0.030 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2015 | 68 | 0.030 |
Why?
| Janus Kinase 2 | 1 | 2014 | 31 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2016 | 304 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2014 | 63 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 164 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2016 | 388 | 0.030 |
Why?
| Folic Acid | 1 | 2015 | 161 | 0.030 |
Why?
| Genes, sis | 1 | 2013 | 1 | 0.030 |
Why?
| Fibroblast Growth Factor 1 | 1 | 2013 | 11 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 21 | 0.030 |
Why?
| Genes, erbB-2 | 1 | 2013 | 26 | 0.030 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2013 | 19 | 0.030 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2013 | 23 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2013 | 155 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 2013 | 70 | 0.030 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2013 | 56 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 68 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2013 | 82 | 0.030 |
Why?
| Peroxidase | 1 | 2013 | 161 | 0.030 |
Why?
| Platinum | 1 | 2013 | 38 | 0.030 |
Why?
| Genomic Instability | 1 | 2013 | 38 | 0.030 |
Why?
| Drug Interactions | 1 | 2014 | 337 | 0.030 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2013 | 157 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2013 | 160 | 0.030 |
Why?
| New Mexico | 1 | 2013 | 58 | 0.030 |
Why?
| Arizona | 1 | 2013 | 68 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2014 | 316 | 0.030 |
Why?
| Molecular Typing | 1 | 2012 | 18 | 0.030 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2013 | 118 | 0.030 |
Why?
| Bacterial Typing Techniques | 1 | 2012 | 40 | 0.030 |
Why?
| Homozygote | 1 | 2013 | 187 | 0.030 |
Why?
| Ohio | 1 | 2012 | 135 | 0.030 |
Why?
| Heterozygote | 1 | 2013 | 250 | 0.030 |
Why?
| Energy Intake | 1 | 2015 | 427 | 0.020 |
Why?
| Catheterization | 1 | 2012 | 158 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 250 | 0.020 |
Why?
| Stress, Physiological | 1 | 2014 | 379 | 0.020 |
Why?
| Smoking Cessation | 1 | 2015 | 374 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2013 | 618 | 0.020 |
Why?
| Microbial Sensitivity Tests | 1 | 2012 | 300 | 0.020 |
Why?
| Haplotypes | 1 | 2012 | 448 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 723 | 0.020 |
Why?
| Surveys and Questionnaires | 2 | 2015 | 4595 | 0.020 |
Why?
| Alleles | 1 | 2013 | 789 | 0.020 |
Why?
| Cell Movement | 2 | 2006 | 863 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2013 | 496 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2016 | 2384 | 0.020 |
Why?
| Weaning | 1 | 2010 | 48 | 0.020 |
Why?
| Renal Dialysis | 1 | 2012 | 375 | 0.020 |
Why?
| Drug Resistance, Neoplasm | 1 | 2013 | 636 | 0.020 |
Why?
| Respiration, Artificial | 1 | 2012 | 528 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 868 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 541 | 0.020 |
Why?
| Tocopherols | 1 | 2008 | 22 | 0.020 |
Why?
| Carotenoids | 1 | 2008 | 33 | 0.020 |
Why?
| Vitamin A | 1 | 2008 | 52 | 0.020 |
Why?
| Diet Records | 1 | 2008 | 76 | 0.020 |
Why?
| Confidence Intervals | 1 | 2008 | 302 | 0.020 |
Why?
| Ascorbic Acid | 1 | 2008 | 110 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 6077 | 0.020 |
Why?
| Factor Analysis, Statistical | 1 | 2008 | 257 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2007 | 133 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2371 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2010 | 436 | 0.020 |
Why?
| Attitude to Health | 1 | 2009 | 398 | 0.020 |
Why?
| Glutathione | 1 | 2007 | 293 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2182 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 2007 | 363 | 0.010 |
Why?
| Mood Disorders | 1 | 2005 | 112 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2007 | 917 | 0.010 |
Why?
| Motor Activity | 1 | 2008 | 635 | 0.010 |
Why?
| Receptors, Estradiol | 1 | 2003 | 3 | 0.010 |
Why?
| Forecasting | 1 | 2005 | 331 | 0.010 |
Why?
| Software Validation | 1 | 2003 | 7 | 0.010 |
Why?
| MEDLINE | 1 | 2003 | 22 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 1471 | 0.010 |
Why?
| Arteriosclerosis | 1 | 2003 | 82 | 0.010 |
Why?
| Feasibility Studies | 1 | 2006 | 735 | 0.010 |
Why?
| Disease | 1 | 2003 | 85 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 206 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2004 | 845 | 0.010 |
Why?
| Double-Blind Method | 1 | 2006 | 1656 | 0.010 |
Why?
| Cluster Analysis | 1 | 2003 | 452 | 0.010 |
Why?
| Rats | 1 | 2010 | 4913 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2003 | 318 | 0.010 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 1168 | 0.010 |
Why?
| Bipolar Disorder | 1 | 2003 | 203 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 742 | 0.010 |
Why?
| Mice, Knockout | 1 | 2007 | 2562 | 0.010 |
Why?
| Comorbidity | 1 | 2005 | 1447 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2006 | 1518 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2006 | 2700 | 0.010 |
Why?
| Gene Expression | 1 | 2003 | 1417 | 0.010 |
Why?
| Epithelial Cells | 1 | 2004 | 946 | 0.010 |
Why?
| Exercise | 1 | 2008 | 1642 | 0.010 |
Why?
| Aging | 1 | 2007 | 1611 | 0.010 |
Why?
| Hypertension | 1 | 2003 | 1052 | 0.010 |
Why?
| Arthritis, Rheumatoid | 1 | 2003 | 1002 | 0.010 |
Why?
|
|
Hines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|